Dental - MPR

Register for your FREE account now and join the thousands of healthcare professionals who have depended on us for over 26 years for accurate, concise, and timely drug information.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Dental Resource Center

Welcome to the MPR Dental Resource Center, where you will find everything you need to make informed clinical decisions.

Drug Monographs

Click on the subcategory below to find drug monographs for that particular area.

News

Review Shows Gum Disease Does Not Cause Heart Disease

Periodontal disease (PD) and atherosclerotic vascular disease (ASVD) share common risk factors, but there is no evidence for a causal relationship between the two, nor evidence that treating PD prevents or alters the outcomes of ASVD.

Gintuit Approved for Oral Soft Tissue Regeneration

Organogenesis announced that the FDA has approved Gintuit (allogeneic cultured keratinocytes and fibroblasts in bovine collagen), a cell-based product for generating new and aesthetically appealing oral gum tissue.

FIRST Mouthwash BLM Compounding Kits Available

CutisPharma announced that it has made available FIRST Mouthwash BLM 4oz and 6oz unit-of-use compounding kits.

FDA Warns of Methemoglobinemia with Benzocaine Topical Products

The FDA notified healthcare professionals and patients that it has continued to receive reports of methemoglobinemia associated with benzocaine products.

FIRST Duke's Mouthwash and FIRST Mary's Mouthwash compounding kits available

CutisPharma has expanded its FIRST Magic Mouthwash line with the launch of FIRST Duke's Mouthwash and FIRST Mary's Mouthwash compounding kits.

DUTOPROL

5/21/2012

AstraZeneca Pharmaceuticals

Pharmacological Class: Cardioselective β₁-blocker + diuretic.

Active Ingredient(s): Metoprolol succinate extended-release, hydrochlorothiazide; 25/12.5mg, 50/12.5mg, 100/12.5mg; tablets.

Indication: Hypertension.

KORLYM

5/14/2012

Corcept Therapeutics

Pharmacological Class: Cortisol receptor blocker.

Active Ingredient(s): Mifepristone 300mg; tabs.

Indication: To control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing’s syndrome who have type 2 diabetes or glucose intolerance and have failed surgery or are not candidates for surgery.

VORAXAZE

5/7/2012

BTG International

Pharmacological Class: Carboxypeptidase enzyme.

Active Ingredient(s): Glucarpidase; 1,000 Units/vial; lyophilized powder for IV injection after reconstitution; preservative-free.

Indication: Treatment of toxic plasma methotrexate (MTX) concentrations (>1 micromole per liter) in patients with delayed MTX clearance due to impaired renal function.